Eli Lilly Cuts 2019 Forecast on Trial Failure, Loxo Deal – U.S. News & World Report
Eli Lilly Cuts 2019 Forecast on Trial Failure, Loxo Deal U.S. News & World Report
(Reuters) – Eli Lilly and Co cut its 2019 profit forecast on Wednesday, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs …
Source: Investment New Feed